← Evidence map

Observational studyClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2019

Trifluridine/Tipiracil (TAS-102) for refractory metastatic colorectal cancer in clinical practice: a feasible alternative for patients with good performance status.

C Carriles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31209792